Wright Medical Group, Inc.

Shareholder Corporation Litigation

Rigrodsky & Long, P.A. Announces Investigation Of Wright Medical Group, Inc. (NASDAQ GS: WMGI) Merger

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Wright Medical Group, Inc. (“Wright Medical” or the “Company”) (NASDAQ GS: WMGI) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to merge with Tornier N.V. (“Tornier”) (NASDAQ GS: TRNX), in a transaction valued at approximately $3.3 billion.

Under the terms of the agreement, each outstanding share of Wright Medical common stock will be exchanged for 1.0309 ordinary shares of Tornier.  Upon completion of the merger, Wright shareholders will own approximately 52% of the shares of the combined company on a fully diluted basis and Tornier shareholders will own approximately 48%.  Based on Tornier’s closing stock price on October 24, 2014, Wright Medical shareholders would have received consideration valued at approximately $24.32.

The investigation concerns whether Wright Medical’s board of directors failed to adequately shop the Company and obtain the best possible value for Wright Medical’s shareholders before entering into an agreement with Tornier.  According to Yahoo! Finance, at least one analyst has issued a price target for Wright Medical stock at $40.00 per share.

If you own the common stock of Wright Medical and purchased your shares before October 27, 2014, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.